DBV Technologies | DBVT - 借入資本





借入資本 変化する 日付
Acadia Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
BioCryst Pharmaceuticals USD 395.2M 33.48M 2026-03
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
DBV Technologies USD 0 0 2025-03
Galectin Therapeutics USD 93.42M 9.08M 2024-06
Halozyme Therapeutics USD 1.94B 206.73M 2026-03
Incyte USD 28.42M 994K 2026-06
Insmed USD 542.22M 1.25M 2026-03
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
PTC Therapeutics USD 535.52M 248.58M 2026-06
Sarepta Therapeutics USD 838.16M 9.19M 2026-03
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
United Therapeutics USD 100M 100M 2024-06